Capital Performance Advisors LLP Invests $257,000 in Bristol-Myers Squibb (NYSE:BMY)
Capital Performance Advisors LLP acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in the third quarter, Holdings Channel reports. The fund acquired 4,961 shares of the biopharmaceutical company’s stock, valued at approximately $257,000. A number of other institutional investors have also recently added to or reduced their stakes in BMY. […]
More Stories
RAPT Therapeutics (NASDAQ:RAPT) and Elanco Animal Health (NYSE:ELAN) Critical Analysis
Elanco Animal Health (NYSE:ELAN – Get Free Report) and RAPT Therapeutics (NASDAQ:RAPT – Get Free Report) are both medical companies,...
Beasley Broadcast Group (NASDAQ:BBGI) Issues Earnings Results
Beasley Broadcast Group (NASDAQ:BBGI – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($2.33) earnings...
HC Wainwright Has Lowered Expectations for Rallybio (NASDAQ:RLYB) Stock Price
Rallybio (NASDAQ:RLYB – Get Free Report) had its target price dropped by stock analysts at HC Wainwright from $6.00 to...
Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, Barclays Analyst Says
Veeva Systems (NYSE:VEEV – Get Free Report) had its target price raised by investment analysts at Barclays from $240.00 to...
Fortinet (NASDAQ:FTNT) Given New $95.00 Price Target at Barclays
Fortinet (NASDAQ:FTNT – Get Free Report) had its target price upped by equities research analysts at Barclays from $85.00 to...
Halliburton (NYSE:HAL) Price Target Cut to $43.00 by Analysts at Barclays
Halliburton (NYSE:HAL – Get Free Report) had its price target decreased by equities researchers at Barclays from $47.00 to $43.00...